21.04.20: Bayer partners with Population Health Research Institute (PHRI) on global clinical research evaluating COVID-19 treatments

Bayer partners with Population Health Research Institute (PHRI) on global clinical research evaluating COVID-19 treatmentsInvestigation of combination therapies including Bayer's chloroquine and interferon beta-1b to foster much needed solutions for patients in fight against coronavirus pandemic / Bayer Canada to make CAD 1.5 million (approximately 1 million euros) financial commitment and to supply products in support of the research / Plans to include more than 60 contributing research locations involving 6.000 patientsmehr ...
Source: Bayer IR Newsfeed: Events - Category: Pharmaceuticals Source Type: news